Does Rallies show Form 4 insider transactions for TELO?

Yes. Rallies tracks TELO insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is TELO research on Rallies investment advice?

No. Rallies provides research, data, and educational context for TELO. It does not provide personalized investment advice.

TELO (Telomir Pharmaceuticals, Inc. Common Stock) Stock Analysis - Insider Trades

Telomir Pharmaceuticals, Inc. Common Stock (TELO) is a publicly traded Healthcare sector company. As of May 20, 2026, TELO trades at $1.26 with a market cap of $81.84M and a P/E ratio of 0.00. TELO moved +3.28% today. Year to date, TELO is -8.96%; over the trailing twelve months it is -51.97%. Its 52-week range spans $1.05 to $7.08. Rallies surfaces TELO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading TELO stock inside the company?

Recent TELO insider activity includes Aminov Erez sold 200, Aminov Erez sold 200, Bay Shore Trust bought 49.00K, Bay Shore Trust bought 40.00K, and Bay Shore Trust bought 49.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

TELO Key Metrics

Key financial metrics for TELO
Metric	Value
Price	$1.26
Market Cap	$81.84M
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.00%
52-Week High	$7.08
52-Week Low	$1.05
Volume	65.80K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$0
Gross Margin	0.00%

Recent TELO Insider Trades

Aminov Erez sold 200 (~$1.20K) on Aug 19, 2024.
Aminov Erez sold 200 (~$1.24K) on Aug 19, 2024.
Bay Shore Trust bought 49.00K (~$343.00K) on Feb 13, 2024.
Bay Shore Trust bought 40.00K (~$280.00K) on Feb 13, 2024.
Bay Shore Trust bought 49.00K (~$343.00K) on Feb 13, 2024.

Latest TELO News

Telomir-Zn Study Demonstrates Dose-Dependent Survival, Reduced Hepatic Copper Burden — May 20, 2026
Telomir Pharmaceuticals Secures FDA IND Clearance for Telomir-Zn, Plans Phase 1/2 TNBC Trial — Apr 30, 2026
Telomir Secures Worldwide Telomir-1 Rights with $1M Upfront and $4M Milestones — Apr 24, 2026
Telo Genomics Appoints CEO with 3.7M Options; Clinical Results by Summer 2026 — Mar 31, 2026
Telomir-Zn Shows Iron-Dependent Tumor Cell Mortality in Triple-Negative Breast Cancer Models — Feb 17, 2026

TELO Analyst Consensus

TELO analyst coverage data. Average price target: $0.00.

Common questions about TELO

Who is trading TELO stock inside the company?: Recent TELO insider activity includes Aminov Erez sold 200, Aminov Erez sold 200, Bay Shore Trust bought 49.00K, Bay Shore Trust bought 40.00K, and Bay Shore Trust bought 49.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for TELO?: Yes. Rallies tracks TELO insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is TELO research on Rallies investment advice?: No. Rallies provides research, data, and educational context for TELO. It does not provide personalized investment advice.